Advanced Malignant Solid Neoplasm

152 clinical trials · Condition

Sort:Newest first Oldest first

◉ Watch Advanced Malignant Solid Neoplasm

Record	Firm	Date
Testing Crizotinib as a Potential Targeted Treatment in Cancers With ROS1 Genetic Changes (MATCH-Subprotocol G) (NCT04439253)	National Cancer Institute (NCI)	2015-08-12
EphA2 siRNA in Treating Patients With Advanced or Recurrent Solid Tumors (NCT01591356)	M.D. Anderson Cancer Center	2015-07-01
Phase IB Study to Evaluate the Safety of Selinexor (KPT-330) in Combination With Multiple Standard Chemotherapy or Immunotherapy Agents in Patients With Advanced Malignancies (NCT02419495)	M.D. Anderson Cancer Center	2015-06-26
Ceritinib and Combination Chemotherapy in Treating Patients With Advanced Solid Tumors or Locally Advanced or Metastatic Pancreatic Cancer (NCT02227940)	Roswell Park Cancer Institute	2015-01-08
Everolimus, Letrozole and Trastuzumab in HR- and HER2/Neu-positive Patients (NCT02152943)	M.D. Anderson Cancer Center	2014-07-17
Trametinib in Treating Patients With Advanced Cancer With or Without Hepatic Dysfunction (NCT02070549)	National Cancer Institute (NCI)	2014-03-10
MPACT Study to Compare Effects of Targeted Drugs on Tumor Gene Variations (NCT01827384)	National Cancer Institute (NCI)	2014-01-07
Cabozantinib S-Malate in Treating Patients With Advanced Solid Tumors and Human Immunodeficiency Virus (NCT01822522)	National Cancer Institute (NCI)	2013-06-21
Ipilimumab and Imatinib Mesylate in Advanced Cancer (NCT01738139)	M.D. Anderson Cancer Center	2013-02-19
Viral Therapy in Treating Patient With Refractory Liver Cancer or Advanced Solid Tumors (NCT01628640)	Mayo Clinic	2012-08-03
Akt Inhibitor MK2206 and Hydroxychloroquine in Treating Patients With Advanced Solid Tumors, Melanoma, Prostate or Kidney Cancer (NCT01480154)	National Cancer Institute (NCI)	2011-11-23
Veliparib and Dinaciclib in Treating Patients With Advanced Solid Tumors (NCT01434316)	National Cancer Institute (NCI)	2011-11-11
Riluzole and Sorafenib Tosylate in Treating Patients With Advanced Solid Tumors or Melanoma (NCT01303341)	National Cancer Institute (NCI)	2011-02-18

Track Advanced Malignant Solid Neoplasm automatically

Every clearance here is in the API, with alerts when new ones post.